BLUE BELL, Pa., June 15, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the company will make presentations at three conferences:
2nd World Cancer Vaccines Summit
Boston, MA, June 22-23
Mark Bagarazzi, MD, Chief Medical Officer
"Advancing Cancer Vaccines Through in vivo Electroporation"
June 22, 2011
2:30 pm ET
Biochemical & Molecular Engineering XVII
Seattle, WA, June 26-30
Bell Harbor Conference Center
Niranjan Sardesai, Ph.D., Sr. VP, Research and Development
"Engineering Effective Vaccines"
June 29, 2011
11:55 am PT
BIO International Convention
Washington, DC, June 27-30
Walter E. Washington Convention Center
Dr. J. Joseph Kim, Ph.D., President & CEO
June 28, 2011
9:45 am ET
About Inovio Pharmaceuticals, Inc.
Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. Its SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio’s proprietary electroporation delivery devices, have been shown to be safe and generate significa
|SOURCE Inovio Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved